BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Novartis
Cipla
US Army
Teva
Harvard Business School
Fuji
Federal Trade Commission
Queensland Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072733

« Back to Dashboard

NDA 072733 describes LEUCOVORIN CALCIUM, which is a drug marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Barr, Epic Pharma Llc, Idt Australia Ltd, Par Pharm, Xanodyne Pharm, Fresenius Kabi Usa, Luitpold, Mylan Labs Ltd, and Sagent Pharms, and is included in forty-one NDAs. It is available from seven suppliers. Additional details are available on the LEUCOVORIN CALCIUM profile page.

The generic ingredient in LEUCOVORIN CALCIUM is leucovorin calcium. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 072733
Tradename:LEUCOVORIN CALCIUM
Applicant:West-ward Pharms Int
Ingredient:leucovorin calcium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 072733
Medical Subject Heading (MeSH) Categories for 072733
Suppliers and Packaging for NDA: 072733
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 072733 ANDA West-Ward Pharmaceuticals Corp. 0054-4496 0054-4496-13 30 TABLET in 1 BOTTLE (0054-4496-13)
LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 072733 ANDA West-Ward Pharmaceuticals Corp. 0054-4496 0054-4496-25 100 TABLET in 1 BOTTLE (0054-4496-25)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Feb 22, 1993TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Novartis
Boehringer Ingelheim
Cerilliant
US Army
Merck
Fuji
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot